Merit Financial Group’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$365K Sell
21,096
-12,666
-38% -$219K ﹤0.01% 1240
2025
Q1
$738K Buy
33,762
+25,806
+324% +$564K 0.01% 772
2024
Q4
$254K Buy
+7,956
New +$254K ﹤0.01% 996